AI Terminal
HEADLAM GROUP PLC
Share Issue/Capital Change • Dec 19, 2022
4695_rns_2022-12-19_9501399a-5643-493a-ba31-518d2091f148.html
Share Issue/Capital Change
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 1780K
Headlam Group PLC
19 December 2022
19 December 2022
Headlam Group plc
(the 'Company')
Exercise of share options / Transfer of treasury shares
Headlam Group plc (LSE: HEAD) announces that, on 16 December 2022, share options granted under the 2020 grant of the Headlam Group Sharesave Scheme ('SAYE') were exercised at the option price of £2.27 per share.
A total of 6,585 ordinary shares have been transferred from treasury stock for the purpose of satisfying the exercise of the share options.
Following the above transfer of treasury stock, the Company holds 2,917,803 ordinary shares as treasury shares.
The total number of ordinary shares in issue (excluding shares held as treasury shares) is 82,721,406 with one voting right per share. Therefore, the total number of voting rights in the Company is 82,721,406.
The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.
| Headlam Group plc | Tel: 01675 433 000 |
| Chris Payne, Chief Executive Catherine Miles, Director of IR and ESG |
Email: [email protected] |
| Panmure Gordon (UK) Limited (Corporate Broker) | Tel: 020 7886 2500 |
| Erik Anderson / Atholl Tweedie | |
| Peel Hunt LLP (Corporate Broker) | Tel: 020 7418 8900 |
| George Sellar / John Welch / Andrew Clark | |
| Alma PR (Financial PR) | Tel: 020 3405 0205 |
| David Ison / Lily Soares Smith / Stephen Samuel | Email: [email protected] |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCFFUFSUEESEIE